183 related articles for article (PubMed ID: 14605986)
1. Gastrointestinal mucositis: a new biological model.
Keefe DM
Support Care Cancer; 2004 Jan; 12(1):6-9. PubMed ID: 14605986
[TBL] [Abstract][Full Text] [Related]
2. Intestinal mucositis: the role of the Bcl-2 family, p53 and caspases in chemotherapy-induced damage.
Bowen JM; Gibson RJ; Cummins AG; Keefe DM
Support Care Cancer; 2006 Jul; 14(7):713-31. PubMed ID: 16453135
[TBL] [Abstract][Full Text] [Related]
3. New pharmacotherapy options for chemotherapy-induced alimentary mucositis.
Wardill HR; Bowen JM; Gibson RJ
Expert Opin Biol Ther; 2014 Mar; 14(3):347-54. PubMed ID: 24387716
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy-induced modifications to gastrointestinal microflora: evidence and implications of change.
Stringer AM; Gibson RJ; Bowen JM; Keefe DM
Curr Drug Metab; 2009 Jan; 10(1):79-83. PubMed ID: 19149515
[TBL] [Abstract][Full Text] [Related]
5. Elemental diet moderates 5-fluorouracil-induced gastrointestinal mucositis through mucus barrier alteration.
Kawashima R; Kawakami F; Maekawa T; Yamamoto H; Koizumi W; Ichikawa T
Cancer Chemother Pharmacol; 2015 Aug; 76(2):269-77. PubMed ID: 26048344
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy-induced mucositis: the role of the gastrointestinal microbiome and toll-like receptors.
Thorpe DW; Stringer AM; Gibson RJ
Exp Biol Med (Maywood); 2013 Jan; 238(1):1-6. PubMed ID: 23479757
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy-induced mucositis: the role of gastrointestinal microflora and mucins in the luminal environment.
Stringer AM; Gibson RJ; Bowen JM; Logan RM; Yeoh AS; Keefe DM
J Support Oncol; 2007 Jun; 5(6):259-67. PubMed ID: 17624050
[TBL] [Abstract][Full Text] [Related]
8. Management of Mucositis During Chemotherapy: From Pathophysiology to Pragmatic Therapeutics.
Van Sebille YZ; Stansborough R; Wardill HR; Bateman E; Gibson RJ; Keefe DM
Curr Oncol Rep; 2015 Nov; 17(11):50. PubMed ID: 26384312
[TBL] [Abstract][Full Text] [Related]
9. Is the pathobiology of chemotherapy-induced alimentary tract mucositis influenced by the type of mucotoxic drug administered?
Logan RM; Stringer AM; Bowen JM; Gibson RJ; Sonis ST; Keefe DM
Cancer Chemother Pharmacol; 2009 Jan; 63(2):239-51. PubMed ID: 18351341
[TBL] [Abstract][Full Text] [Related]
10. Characterisation of mucosal changes in the alimentary tract following administration of irinotecan: implications for the pathobiology of mucositis.
Logan RM; Gibson RJ; Bowen JM; Stringer AM; Sonis ST; Keefe DM
Cancer Chemother Pharmacol; 2008 Jun; 62(1):33-41. PubMed ID: 17703303
[TBL] [Abstract][Full Text] [Related]
11. Advances in the Use of Anti-inflammatory Agents to Manage Chemotherapy-induced Oral and Gastrointestinal Mucositis.
Mahendran VJ; Stringer AM; Semple SJ; Song Y; Garg S
Curr Pharm Des; 2018; 24(14):1518-1532. PubMed ID: 29629657
[TBL] [Abstract][Full Text] [Related]
12. Severe mucositis: how can nutrition help?
Keefe DM; Rassias G; O'Neil L; Gibson RJ
Curr Opin Clin Nutr Metab Care; 2007 Sep; 10(5):627-31. PubMed ID: 17693748
[TBL] [Abstract][Full Text] [Related]
13. The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: pathobiology, animal models and cytotoxic drugs.
Logan RM; Stringer AM; Bowen JM; Yeoh AS; Gibson RJ; Sonis ST; Keefe DM
Cancer Treat Rev; 2007 Aug; 33(5):448-60. PubMed ID: 17507164
[TBL] [Abstract][Full Text] [Related]
14. Risk analysis, diagnosis and management of gastrointestinal mucositis in pediatric cancer patients.
Kuiken NS; Rings EH; Tissing WJ
Crit Rev Oncol Hematol; 2015 Apr; 94(1):87-97. PubMed ID: 25560731
[TBL] [Abstract][Full Text] [Related]
15. Oral integrity and salivary profile in myeloma patients undergoing high-dose therapy followed by autologous SCT.
Avivi I; Avraham S; Koren-Michowitz M; Zuckerman T; Aviv A; Ofran Y; Benyamini N; Nagler A; Rowe JM; Nagler RM
Bone Marrow Transplant; 2009 May; 43(10):801-6. PubMed ID: 19029961
[TBL] [Abstract][Full Text] [Related]
16. Serum Bovine Immunoglobulin for Chemotherapy-Induced Gastrointestinal Mucositis.
Arikapudi S; Rashid S; Al Almomani LA; Treece J; Baumrucker SJ
Am J Hosp Palliat Care; 2018 May; 35(5):814-817. PubMed ID: 29020798
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers of regimen-related mucosal injury.
Gibson RJ; Bowen JM
Cancer Treat Rev; 2011 Oct; 37(6):487-93. PubMed ID: 21689887
[TBL] [Abstract][Full Text] [Related]
18. Dark Agouti rat model of chemotherapy-induced mucositis: establishment and current state of the art.
Vanhoecke B; Bateman E; Mayo B; Vanlancker E; Stringer A; Thorpe D; Keefe D
Exp Biol Med (Maywood); 2015 Jun; 240(6):725-41. PubMed ID: 25966981
[TBL] [Abstract][Full Text] [Related]
19. Measuring tools for gastrointestinal toxicity.
Butler RN
Curr Opin Support Palliat Care; 2008 Mar; 2(1):35-9. PubMed ID: 18685392
[TBL] [Abstract][Full Text] [Related]
20. Gastrointestinal mucositis: focus on the treatment of the effects of chemotherapy and radiotherapy on the rectum.
Zur E
Int J Pharm Compd; 2012; 16(2):117-24. PubMed ID: 23050323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
